Epigenetic landscape of small cell lung cancer: small image of a giant recalcitrant disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epigenetic landscape of small cell lung cancer: small image of a giant recalcitrant disease
Authors
Keywords
-
Journal
SEMINARS IN CANCER BIOLOGY
Volume 83, Issue -, Pages 57-76
Publisher
Elsevier BV
Online
2020-11-19
DOI
10.1016/j.semcancer.2020.11.006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- First-Line Treatment With Atezolizumab Plus Nab-Paclitaxel for Advanced Triple-Negative Breast Cancer
- (2020) Xiuhua Weng et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Bivalent promoter hypermethylation in cancer is linked to the H327me3/H3K4me3 ratio in embryonic stem cells
- (2020) Donnchadh S. Dunican et al. BMC BIOLOGY
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Pre-clinical models of small cell lung cancer and the validation of therapeutic targets
- (2020) Jane S. Y. Sui et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Structure of nucleosome-bound human BAF complex
- (2020) Shuang He et al. SCIENCE
- Chromatin accessibility analysis reveals regulatory dynamics of developing human retina and hiPSC-derived retinal organoids
- (2020) Haohuan Xie et al. Science Advances
- MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate
- (2020) Abbie S. Ireland et al. CANCER CELL
- Epigenetic therapies and potential drugs for treating human cancer
- (2020) Shiqi Lin et al. CURRENT DRUG TARGETS
- Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer
- (2020) Roberta Roncarati et al. Molecular Oncology
- NFI transcription factors provide chromatin access to maintain stem cell identity while preventing unintended lineage fate choices
- (2020) Rene C. Adam et al. NATURE CELL BIOLOGY
- Genetic and epigenetic intratumor heterogeneity impacts prognosis of lung adenocarcinoma
- (2020) Xing Hua et al. Nature Communications
- A Genome-wide CRISPR Screen Reveals a Role for the Non-canonical Nucleosome-Remodeling BAF Complex in Foxp3 Expression and Regulatory T Cell Function
- (2020) Chin-San Loo et al. IMMUNITY
- hTERT promoter methylation promotes small cell lung cancer progression and radiotherapy resistance
- (2020) Guangsheng Zhai et al. JOURNAL OF RADIATION RESEARCH
- An atlas of dynamic chromatin landscapes in mouse fetal development
- (2020) David U. Gorkin et al. NATURE
- The roles of histone variants in fine-tuning chromatin organization and function
- (2020) Sara Martire et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Epigenetic Therapies for Cancer
- (2020) Susan E. Bates NEW ENGLAND JOURNAL OF MEDICINE
- Semisynthesis of site-specifically succinylated histone reveals that succinylation regulates nucleosome unwrapping rate and DNA accessibility
- (2020) Yihang Jing et al. NUCLEIC ACIDS RESEARCH
- DNA polymerase beta modulates cancer progression via enhancing CDH13 expression by promoter demethylation
- (2020) Meina Wang et al. ONCOGENE
- Nucleosome allostery in pioneer transcription factor binding
- (2020) Cheng Tan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A partially disordered region connects gene repression and activation functions of EZH2
- (2020) Lianying Jiao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Contribution of Epigenetics to Cancer Immunotherapy
- (2020) Lorea Villanueva et al. TRENDS IN IMMUNOLOGY
- Single-cell epigenomics in cancer: charting a course to clinical impact
- (2020) Danielle R Bond et al. Epigenomics
- ASXL3 bridges BRD4 to BAP1 complex and governs enhancer activity in small cell lung cancer
- (2020) Aileen Patricia Szczepanski et al. Genome Medicine
- Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targets
- (2020) Julia Krushkal et al. Clinical Epigenetics
- ARID1A loss in neuroblastoma promotes the adrenergic-to-mesenchymal transition by regulating enhancer-mediated gene expression
- (2020) Hui Shi et al. Science Advances
- Coordinated regulation of cellular identity–associated H3K4me3 breadth by the COMPASS family
- (2020) Christie C. Sze et al. Science Advances
- Small Cell Lung Cancer from Traditional to Innovative Therapeutics: Building a Comprehensive Network to Optimize Clinical and Translational Research
- (2020) Shanmuga Subbiah et al. Journal of Clinical Medicine
- DrugSniper, a Tool to Exploit Loss-Of-Function Screens, Identifies CREBBP as a Predictive Biomarker of VOLASERTIB in Small Cell Lung Carcinoma (SCLC)
- (2020) Fernando Carazo et al. Cancers
- Epigenetic plasticity in metastatic dormancy: mechanisms and therapeutic implications
- (2020) Nathaniel J. Robinson et al. Annals of Translational Medicine
- Histone Variants: The Nexus of Developmental Decisions and Epigenetic Memory
- (2020) Benjamin Loppin et al. Annual Review of Genetics
- MYCN drives chemoresistance in small cell lung cancer while USP7 inhibition can restore chemosensitivity
- (2020) Eli Grunblatt et al. GENES & DEVELOPMENT
- Structural basis for histone variant H3tK27me3 recognition by PHF1 and PHF19
- (2020) Cheng Dong et al. eLife
- Immunotherapy in Small Cell Lung Cancer
- (2020) Giovanna Esposito et al. Cancers
- Epigenomic promoter alterations predict for benefit from immune checkpoint inhibition in metastatic gastric cancer
- (2019) R Sundar et al. ANNALS OF ONCOLOGY
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer
- (2019) Biagio Ricciuti et al. Journal for ImmunoTherapy of Cancer
- Are there any theranostic biomarkers in small cell lung carcinoma?
- (2019) Federica Pezzuto et al. Journal of Thoracic Disease
- Taking SCLC on a Bad LSD(1) Trip One NOTCH Further
- (2019) Jun Kim et al. TRENDS IN MOLECULAR MEDICINE
- Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition
- (2019) Arnaud Augert et al. Science Signaling
- Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer
- (2019) Benjamin P. Levy et al. EUROPEAN JOURNAL OF CANCER
- Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma
- (2019) Marie Auvray et al. EUROPEAN JOURNAL OF CANCER
- Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer
- (2019) Matthew D. Hellmann et al. CANCER CELL
- Dissecting the role of H3K27 acetylation and methylation in PRC2 mediated control of cellular identity
- (2019) Elisa Lavarone et al. Nature Communications
- MYC-Driven Small-Cell Lung Cancer is Metabolically Distinct and Vulnerable to Arginine Depletion
- (2019) Milind D. Chalishazar et al. CLINICAL CANCER RESEARCH
- Ascl1-induced Wnt11 regulates neuroendocrine differentiation, cell proliferation, and E-cadherin expression in small-cell lung cancer and Wnt11 regulates small-cell lung cancer biology
- (2019) Yuki Tenjin et al. LABORATORY INVESTIGATION
- Advances in epigenetics link genetics to the environment and disease
- (2019) Giacomo Cavalli et al. NATURE
- Roles and regulation of histone methylation in animal development
- (2019) Ashwini Jambhekar et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Tumor Heterogeneity Underlies Differential Cisplatin Sensitivity in Mouse Models of Small-Cell Lung Cancer
- (2019) Franziska Böttger et al. Cell Reports
- Comprehensive genomic profiling of small cell lung cancer in Chinese patients and the implications for therapeutic potential
- (2019) Jing Hu et al. Cancer Medicine
- An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer
- (2019) Marian L. Burr et al. CANCER CELL
- Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non–Small Cell Lung Cancer
- (2019) Jhanelle E. Gray et al. CLINICAL CANCER RESEARCH
- Challenging the recalcitrant disease—developing molecularly driven treatments for small cell lung cancer
- (2019) Daisy W.S. Mak et al. EUROPEAN JOURNAL OF CANCER
- The emerging role of epigenetic therapeutics in immuno-oncology
- (2019) Michael J. Topper et al. Nature Reviews Clinical Oncology
- Combining epigenetic drugs with other therapies for solid tumours — past lessons and future promise
- (2019) Daphné Morel et al. Nature Reviews Clinical Oncology
- TSC1/mTOR-controlled metabolic–epigenetic cross talk underpins DC control of CD8+ T-cell homeostasis
- (2019) Lei Shi et al. PLOS BIOLOGY
- Subtyping Lung Cancer Using DNA Methylation in Liquid Biopsies
- (2019) Nunes et al. Journal of Clinical Medicine
- Rare Pulmonary Neuroendocrine Cells Are Stem Cells Regulated by Rb, p53, and Notch
- (2019) Youcef Ouadah et al. CELL
- The KDM5A/RBP2 histone demethylase represses NOTCH signaling to sustain neuroendocrine differentiation and promote small cell lung cancer tumorigenesis
- (2019) Matthew G. Oser et al. GENES & DEVELOPMENT
- Profiling of circulating free DNA using targeted and genome wide sequencing in patients with Small Cell Lung Cancer
- (2019) Sumitra Mohan et al. Journal of Thoracic Oncology
- Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
- (2019) Luis Paz-Ares et al. LANCET
- Immunotherapy: a new era in small-cell lung cancer
- (2019) Thorsten Oliver Goetze LANCET
- Identification of DHODH as a therapeutic target in small cell lung cancer
- (2019) Leanne Li et al. Science Translational Medicine
- Cigarette smoke affects the onco-suppressor DAB2IP expression in bronchial epithelial cells of COPD patients
- (2019) Giulia Anzalone et al. Scientific Reports
- Bromodomain and Extraterminal Proteins as Novel Epigenetic Targets for Renal Diseases
- (2019) Jose Luis Morgado-Pascual et al. Frontiers in Pharmacology
- LSD1/KDM1A inhibitors in clinical trials: advances and prospects
- (2019) Yuan Fang et al. Journal of Hematology & Oncology
- Epigenetics and the Developmental Origins of Health and Disease: Parental environment signalling to the epigenome, critical time windows and sculpting the adult phenotype
- (2019) Sofiane Safi-Stibler et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Current Landscape of Epigenetics in Lung Cancer: Focus on the Mechanism and Application
- (2019) Yuan-Xiang Shi et al. Journal of Oncology
- Phase I trial of belinostat with cisplatin and etoposide in advanced solid tumors, with a focus on neuroendocrine and small cell cancers of the lung
- (2018) Sanjeeve Balasubramaniam et al. ANTI-CANCER DRUGS
- Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer
- (2018) Matthew D. Hellmann et al. CANCER CELL
- NK cells mediate synergistic antitumor effects of combined inhibition of HDAC6 and BET in a SCLC preclinical model
- (2018) Yan Liu et al. CANCER RESEARCH
- Syntaphilin Ubiquitination Regulates Mitochondrial Dynamics And Tumor Cell Movements
- (2018) Jae Ho Seo et al. CANCER RESEARCH
- LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade
- (2018) Wanqiang Sheng et al. CELL
- Mammalian target of rapamycin complex 2 (mTORC2) controls glycolytic gene expression by regulating Histone H3 Lysine 56 acetylation
- (2018) Raghavendra Vadla et al. CELL CYCLE
- POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer
- (2018) Yu-Han Huang et al. GENES & DEVELOPMENT
- Identifying a missing lineage driver in a subset of lung neuroendocrine tumors
- (2018) Karine Pozo et al. GENES & DEVELOPMENT
- Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer
- (2018) M. Catherine Pietanza et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of Nivolumab versus Docetaxel on Health-Related Quality of Life and Symptoms in Patients with Advanced Squamous Non–Small Cell Lung Cancer: Results from the CheckMate 017 Study
- (2018) Martin Reck et al. Journal of Thoracic Oncology
- Phase II Study of Maintenance Pembrolizumab in Patients with Extensive-Stage Small Cell Lung Cancer (SCLC)
- (2018) Shirish M. Gadgeel et al. Journal of Thoracic Oncology
- Genomic alterations of plasma cell-free DNAs in small cell lung cancer and their clinical relevance
- (2018) Meijun Du et al. LUNG CANCER
- A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors
- (2018) Mariano J. Alvarez et al. NATURE GENETICS
- Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy
- (2018) Lu Wang et al. NATURE MEDICINE
- Epigenome-based cancer risk prediction: rationale, opportunities and challenges
- (2018) Martin Widschwendter et al. Nature Reviews Clinical Oncology
- Analysis of DNA methylation in cancer: location revisited
- (2018) Alexander Koch et al. Nature Reviews Clinical Oncology
- Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
- (2018) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
- (2018) Patrick M. Forde et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chromatin regulation and immune escape
- (2018) Ehsan Ghorani et al. SCIENCE
- A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing
- (2018) Deng Pan et al. SCIENCE
- Distinct epigenomic patterns are associated with haploinsufficiency and predict risk genes of developmental disorders
- (2018) Xinwei Han et al. Nature Communications
- STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS -Mutant Lung Adenocarcinoma
- (2018) Ferdinandos Skoulidis et al. Cancer Discovery
- PD-L1 Expression, Tumor Mutational Burden, and Response to Immunotherapy in Patients with MET exon 14 Altered Lung Cancers
- (2018) J K Sabari et al. ANNALS OF ONCOLOGY
- Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy
- (2018) Subhankar Biswas et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
- (2018) Leora Horn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade
- (2018) Ye Qin et al. ONCOGENE
- Intertumoral Heterogeneity in SCLC Is Influenced by the Cell Type of Origin
- (2018) Dian Yang et al. Cancer Discovery
- Crebbp loss drives small cell lung cancer and increases sensitivity to HDAC inhibition
- (2018) Deshui Jia et al. Cancer Discovery
- A Human Adult Stem Cell Signature Marks Aggressive Variants across Epithelial Cancers
- (2018) Bryan A. Smith et al. Cell Reports
- BET Bromodomain Inhibition Cooperates with PD-1 Blockade to Facilitate Antitumor Response inKras-Mutant Non–Small Cell Lung Cancer
- (2018) Dennis O. Adeegbe et al. Cancer Immunology Research
- Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis
- (2018) Michäel Duruisseaux et al. Lancet Respiratory Medicine
- Pharmacological Inhibition of LSD1 for Cancer Treatment
- (2018) Guan-Jun Yang et al. MOLECULES
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reprogramming normal human epithelial tissues to a common, lethal neuroendocrine cancer lineage
- (2018) Jung Wook Park et al. SCIENCE
- DNA methylation analysis of selected genes for the detection of early-stage lung cancer using circulating cell-free DNA
- (2018) Zhiping Yang et al. Advances in Clinical and Experimental Medicine
- EGFR-Mutant SCLC Exhibits Heterogeneous Phenotypes and Resistance to Common Antineoplastic Drugs
- (2018) Chih-An Lin et al. Journal of Thoracic Oncology
- Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032
- (2018) Neal Ready et al. Journal of Thoracic Oncology
- Comprehensive immunohistochemical analysis of histone deacetylases in pancreatic neuroendocrine tumors: HDAC5 as a predictor of poor clinical outcome
- (2017) Eckhard Klieser et al. HUMAN PATHOLOGY
- H3K4 Methyltransferase Activity Is Required for MLL4 Protein Stability
- (2017) Younghoon Jang et al. JOURNAL OF MOLECULAR BIOLOGY
- Small Cell Lung Cancer Exhibits Frequent Inactivating Mutations in the Histone Methyltransferase KMT2D/MLL2 : CALGB 151111 (Alliance)
- (2017) Arnaud Augert et al. Journal of Thoracic Oncology
- Lack of response to nivolumab in a patient with EGFR -mutant non-small cell lung cancer adenocarcinoma sub-type transformed to small cell lung cancer
- (2017) Nadza Tokaca et al. LUNG CANCER
- O 6 -Methylguanine-DNA methyltransferase (MGMT): A drugable target in lung cancer?
- (2017) Birgitta I. Hiddinga et al. LUNG CANCER
- MYC expression correlates with PD-L1 expression in non-small cell lung cancer
- (2017) Eun Young Kim et al. LUNG CANCER
- Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer
- (2017) Jing Shan Lim et al. NATURE
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epigenetic plasticity and the hallmarks of cancer
- (2017) William A. Flavahan et al. SCIENCE
- Lung cancer epigenetics: From knowledge to applications
- (2017) Michaël Duruisseaux et al. SEMINARS IN CANCER BIOLOGY
- O6-methyl-guanine-DNA methyltransferase methylation and IDH1/2 mutation in small cell lung cancer
- (2017) Hongyang Lu et al. Experimental and Therapeutic Medicine
- Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
- (2017) Zachary R. Chalmers et al. Genome Medicine
- NFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITF
- (2017) Mitchell E. Fane et al. EBioMedicine
- The world of protein acetylation
- (2016) Adrian Drazic et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells
- (2016) Chun-Hao Pan et al. BMC CANCER
- Opening a Chromatin Gate to Metastasis
- (2016) John D. Minna et al. CELL
- Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility
- (2016) Sarah K. Denny et al. CELL
- Genomic Profiling of Large-Cell Neuroendocrine Carcinoma of the Lung
- (2016) Tomohiro Miyoshi et al. CLINICAL CANCER RESEARCH
- HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma
- (2016) Hong Zheng et al. CLINICAL CANCER RESEARCH
- Genetic requirement forMycland efficacy of RNA Pol I inhibition in mouse models of small cell lung cancer
- (2016) Dong-Wook Kim et al. GENES & DEVELOPMENT
- Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer
- (2016) Martin Reck et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
- (2016) Scott J Antonia et al. LANCET ONCOLOGY
- A Novel LSD1 Inhibitor T-3775440 Disrupts GFI1B-Containing Complex Leading to Transdifferentiation and Impaired Growth of AML Cells
- (2016) Yoshinori Ishikawa et al. MOLECULAR CANCER THERAPEUTICS
- Distinct features of H3K4me3 and H3K27me3 chromatin domains in pre-implantation embryos
- (2016) Xiaoyu Liu et al. NATURE
- Disease variants alter transcription factor levels and methylation of their binding sites
- (2016) Marc Jan Bonder et al. NATURE GENETICS
- Shining light on novel targets and therapies
- (2016) Charles M. Rudin et al. Nature Reviews Clinical Oncology
- MYC regulates the antitumor immune response through CD47 and PD-L1
- (2016) S. C. Casey et al. SCIENCE
- Small cell lung cancer: Time to revisit DNA-damaging chemotherapy
- (2016) Anish Thomas et al. Science Translational Medicine
- Small cell lung cancer, an epithelial to mesenchymal transition (EMT)-like cancer: significance of inactive Notch signaling and expression of achaete-scute complex homologue 1
- (2016) Takaaki Ito et al. Human Cell
- Identification and Targeting of Long-Term Tumor-Propagating Cells in Small Cell Lung Cancer
- (2016) Nadine S. Jahchan et al. Cell Reports
- Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients
- (2016) Ekaterina A. Semenova et al. Cell Reports
- Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer
- (2016) Narsis Attar et al. Cold Spring Harbor Perspectives in Medicine
- Combination with vorinostat overcomes ABT-263 (navitoclax) resistance of small cell lung cancer
- (2015) Wataru Nakajima et al. CANCER BIOLOGY & THERAPY
- Altering the Course of Small Cell Lung Cancer: Targeting Cancer Stem Cells via LSD1 Inhibition
- (2015) C. Allison Stewart et al. CANCER CELL
- A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC
- (2015) Helai P. Mohammad et al. CANCER CELL
- KAT6B Is a Tumor Suppressor Histone H3 Lysine 23 Acetyltransferase Undergoing Genomic Loss in Small Cell Lung Cancer
- (2015) Laia Simó-Riudalbas et al. CANCER RESEARCH
- Functional proteomics of the epigenetic regulators ASXL1, ASXL2 and ASXL3: a convergence of proteomics and epigenetics for translational medicine
- (2015) Masaru Katoh Expert Review of Proteomics
- Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial
- (2015) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
- (2015) Dirk Schadendorf et al. JOURNAL OF CLINICAL ONCOLOGY
- Small-cell lung cancer: local therapy for a systemic disease?
- (2015) Jan P van Meerbeeck et al. LANCET
- Interaction with WDR5 Promotes Target Gene Recognition and Tumorigenesis by MYC
- (2015) Lance R. Thomas et al. MOLECULAR CELL
- Substantial contribution of extrinsic risk factors to cancer development
- (2015) Song Wu et al. NATURE
- Comprehensive genomic profiles of small cell lung cancer
- (2015) Julie George et al. NATURE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2
- (2015) J T Poirier et al. ONCOGENE
- Posttranscriptional silencing of the lncRNA MALAT1 by miR-217 inhibits the epithelial–mesenchymal transition via enhancer of zeste homolog 2 in the malignant transformation of HBE cells induced by cigarette smoke extract
- (2015) Lu Lu et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Epigenetics of lung cancer
- (2015) Scott M. Langevin et al. Translational Research
- EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo Activity
- (2015) John E. Campbell et al. ACS Medicinal Chemistry Letters
- Targeting BET bromodomains for cancer treatment
- (2015) Marie Jung et al. Epigenomics
- EZH2 promotes progression of small cell lung cancer by suppressing the TGF-β-Smad-ASCL1 pathway
- (2015) Fumihiko Murai et al. Cell Discovery
- Small cell lung cancer: Where do we go from here?
- (2014) Lauren Averett Byers et al. CANCER
- Rapamycin Rescues ABT-737 Efficacy in Small Cell Lung Cancer
- (2014) E. E. Gardner et al. CANCER RESEARCH
- Most common ‘sporadic’ cancers have a significant germline genetic component
- (2014) Yi Lu et al. HUMAN MOLECULAR GENETICS
- Genome-wide and single-cell analyses reveal a context dependent relationship between CBP recruitment and gene expression
- (2014) Lawryn H. Kasper et al. NUCLEIC ACIDS RESEARCH
- Targets in small cell lung cancer
- (2013) Beverly A. Teicher BIOCHEMICAL PHARMACOLOGY
- Global DNA Hypomethylation in Peripheral Blood Mononuclear Cells as a Biomarker of Cancer Risk
- (2013) S. Friso et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- The fate is not always written in the genes: Epigenomics in epidemiologic studies
- (2013) Scott M. Langevin et al. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
- A Phase II Study of the Histone Deacetylase Inhibitor Panobinostat (LBH589) in Pretreated Patients with Small-Cell Lung Cancer
- (2013) Filippo de Marinis et al. Journal of Thoracic Oncology
- DNA methylation dynamics in health and disease
- (2013) Yehudit Bergman et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- NeuroD1 regulates survival and migration of neuroendocrine lung carcinomas via signaling molecules TrkB and NCAM
- (2013) J. K. Osborne et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Small Cell Lung Cancer: Therapies and Targets
- (2013) Rathi N. Pillai et al. SEMINARS IN ONCOLOGY
- H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation
- (2013) Ji-Eun Lee et al. eLife
- Combination of HDAC and topoisomerase inhibitors in small cell lung cancer
- (2012) Jhanelle Gray et al. CANCER BIOLOGY & THERAPY
- Higher Expression of Caveolin-1 Inhibits Human Small Cell Lung Cancer (SCLC) ApoptosisIn Vitro
- (2012) Xiaohan Yang et al. CANCER INVESTIGATION
- Phase II Trial of Temozolomide in Patients with Relapsed Sensitive or Refractory Small Cell Lung Cancer, with Assessment of Methylguanine-DNA Methyltransferase as a Potential Biomarker
- (2012) M. C. Pietanza et al. CLINICAL CANCER RESEARCH
- The significance of epigenetic alterations in lung carcinogenesis
- (2012) Ewa Brzeziańska et al. MOLECULAR BIOLOGY REPORTS
- Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer
- (2012) Charles M Rudin et al. NATURE GENETICS
- Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
- (2012) Martin Peifer et al. NATURE GENETICS
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- The DNA methylation landscape of small cell lung cancer suggests a differentiation defect of neuroendocrine cells
- (2012) S Kalari et al. ONCOGENE
- Caveolin-1 interferes cell growth of lung cancer NCI-H446 cell through the interactions with phospho-ERK1/2, estrogen receptor and progestin receptor
- (2011) Ming-Zhong Sun et al. BIOMEDICINE & PHARMACOTHERAPY
- The role of EZH2 in tumour progression
- (2011) C-J Chang et al. BRITISH JOURNAL OF CANCER
- The Effect of Adenovirus-Mediated Gene Expression of FHIT in Small Cell Lung Cancer Cells
- (2011) Roza Zandi et al. CANCER INVESTIGATION
- Lung Cancer: Epidemiology, Etiology, and Prevention
- (2011) Charles S. Dela Cruz et al. CLINICS IN CHEST MEDICINE
- Nuclear factor I/B is an oncogene in small cell lung cancer
- (2011) A. L. Dooley et al. GENES & DEVELOPMENT
- Small-cell lung cancer
- (2011) Jan P van Meerbeeck et al. LANCET
- A continuum model for tumour suppression
- (2011) Alice H. Berger et al. NATURE
- LSD1 regulates the balance between self-renewal and differentiation in human embryonic stem cells
- (2011) Antonio Adamo et al. NATURE CELL BIOLOGY
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epigenetic Modifications of Histone H4 in Lung Neuroendocrine Tumors
- (2011) Faqian Li et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Preclinical evidence for a beneficial impact of valproate on the response of small cell lung cancer to first-line chemotherapy
- (2010) Roland Hubaux et al. EUROPEAN JOURNAL OF CANCER
- Histone demethylase KDM5A is an integral part of the core Notch-RBP-J repressor complex
- (2010) R. Liefke et al. GENES & DEVELOPMENT
- MYST Family Lysine Acetyltransferase Facilitates Ataxia Telangiectasia Mutated (ATM) Kinase-mediated DNA Damage Response inToxoplasma gondii
- (2010) Nathalie Vonlaufen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phase II Study of the Histone Deacetylase Inhibitor Romidepsin in Relapsed Small Cell Lung Cancer (Cancer and Leukemia Group B 30304)
- (2010) Gregory A. Otterson et al. Journal of Thoracic Oncology
- Combinations of DNA Methyltransferase and Histone Deacetylase Inhibitors Induce DNA Damage in Small Cell Lung Cancer Cells: Correlation of Resistance with IFN-Stimulated Gene Expression
- (2010) Wioleta Luszczek et al. MOLECULAR CANCER THERAPEUTICS
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Achaete-Scute Complex Homologue 1 Regulates Tumor-Initiating Capacity in Human Small Cell Lung Cancer
- (2009) T. Jiang et al. CANCER RESEARCH
- Histone modifications at human enhancers reflect global cell-type-specific gene expression
- (2009) Nathaniel D. Heintzman et al. NATURE
- Linking DNA methylation and histone modification: patterns and paradigms
- (2009) Howard Cedar et al. NATURE REVIEWS GENETICS
- Epigenetic Cross-Talk between DNA Methylation and Histone Modifications in Human Cancers
- (2009) Yutaka Kondo YONSEI MEDICAL JOURNAL
- DNA hypomethylation in cancer cells
- (2009) Melanie Ehrlich Epigenomics
- Promoter Hypermethylation of Hallmark Cancer Genes in Atypical Adenomatous Hyperplasia of the Lung
- (2008) J. D.F. Licchesi et al. CLINICAL CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started